GB1531368A - 2'-((3,6-dihydro-4-phenyl-1(2h)-pyridinyl or 4-phenyl-1-piperidinyl)-alkylaminocarbonyl)(1,1'-biphenyl)-2-carboxylic acids - Google Patents

2'-((3,6-dihydro-4-phenyl-1(2h)-pyridinyl or 4-phenyl-1-piperidinyl)-alkylaminocarbonyl)(1,1'-biphenyl)-2-carboxylic acids

Info

Publication number
GB1531368A
GB1531368A GB38471/76A GB3847176A GB1531368A GB 1531368 A GB1531368 A GB 1531368A GB 38471/76 A GB38471/76 A GB 38471/76A GB 3847176 A GB3847176 A GB 3847176A GB 1531368 A GB1531368 A GB 1531368A
Authority
GB
United Kingdom
Prior art keywords
phenyl
alkylaminocarbonyl
pyridinyl
piperidinyl
biphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38471/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB1531368A publication Critical patent/GB1531368A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB38471/76A 1975-09-25 1976-09-16 2'-((3,6-dihydro-4-phenyl-1(2h)-pyridinyl or 4-phenyl-1-piperidinyl)-alkylaminocarbonyl)(1,1'-biphenyl)-2-carboxylic acids Expired GB1531368A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/616,735 US3995045A (en) 1975-09-25 1975-09-25 2'-[(3,6-Dihydro-phenyl-1(2H)pyridinyl)alkylaminocarbonyl][1,1'-biphenyl]-2-carboxylic acids

Publications (1)

Publication Number Publication Date
GB1531368A true GB1531368A (en) 1978-11-08

Family

ID=24470750

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38471/76A Expired GB1531368A (en) 1975-09-25 1976-09-16 2'-((3,6-dihydro-4-phenyl-1(2h)-pyridinyl or 4-phenyl-1-piperidinyl)-alkylaminocarbonyl)(1,1'-biphenyl)-2-carboxylic acids

Country Status (6)

Country Link
US (1) US3995045A (enExample)
JP (1) JPS5239684A (enExample)
CA (1) CA1089467A (enExample)
DE (1) DE2643127A1 (enExample)
FR (1) FR2325375A1 (enExample)
GB (1) GB1531368A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140379A (ja) * 1982-02-09 1983-08-20 イビデン株式会社 型彫り放電加工用黒鉛電極
US4786755A (en) * 1985-06-03 1988-11-22 Warner-Lambert Company Diphenic acid monoamides
US4602023A (en) * 1985-06-03 1986-07-22 Warner-Lambert Company Diphenic acid monoamides
JPH0662355B2 (ja) * 1986-04-23 1994-08-17 イビデン株式会社 半導体融解装置用黒鉛部材の製造方法
JPH0639356B2 (ja) * 1986-05-16 1994-05-25 イビデン株式会社 液相エピタキシヤル成長装置用ボ−ト部材
JPH0753635B2 (ja) * 1986-07-08 1995-06-07 電気化学工業株式会社 ガラス状炭素被覆サセプタ−及びその製造方法
JP2553389B2 (ja) * 1988-12-26 1996-11-13 東芝セラミックス株式会社 Cvd装置用カーボン治具
AU2002227269A1 (en) * 2000-11-07 2002-06-03 Bristol-Myers Squibb Company Acid derivatives useful as serine protease inhibitors
US6906192B2 (en) 2000-11-07 2005-06-14 Bristol Myers Squibb Company Processes for the preparation of acid derivatives useful as serine protease inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2929818A (en) * 1958-12-22 1960-03-22 Janssen Paul Adriaan Jan 4-phenyl-1, 2, 3, 6-tetrahydropyridine-1-alkanoic acid amides
US3927006A (en) * 1970-06-19 1975-12-16 Hoffmann La Roche Tetrahydropyridine derivatives

Also Published As

Publication number Publication date
FR2325375B1 (enExample) 1979-09-28
DE2643127A1 (de) 1977-04-07
CA1089467A (en) 1980-11-11
FR2325375A1 (fr) 1977-04-22
US3995045A (en) 1976-11-30
JPS5239684A (en) 1977-03-28

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
AU1405576A (en) 103-dihydroimidazo (4,5-6) pyridin -2-ones
IL51213A0 (en) The production of 4,4'-isopropylidene-bis-(2,6-dibromophenol)
GB1524917A (en) Gona-1,9(10)-dienes
GB1531368A (en) 2'-((3,6-dihydro-4-phenyl-1(2h)-pyridinyl or 4-phenyl-1-piperidinyl)-alkylaminocarbonyl)(1,1'-biphenyl)-2-carboxylic acids
PH14942A (en) 7-acylamino-8-oxo-3-oxa-1-azabicyclo(4.2.0)octane-2-carboxylic acid derivatives
JPS52121171A (en) Brake actuater
GB1556279A (en) 3,7-disubstituted-3-cephem-4-carboxylic acids
AU508891B2 (en) 5,6-dihydro-prostacyclin analogs
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
AU505725B2 (en) 2, 9-dioxatricyclo ( 4,3,1,03,70 dercanes
IL52884A0 (en) The preparation of 2,3-cycloalkenopyridines
AU509971B2 (en) 13, 14-ethynyl Prostaglandin Analogues
AU501405B2 (en) Lower allergenic lanolin
AU507282B2 (en) 3, 3-Dimethylpent-4-Endic Acid
KE3185A (en) 2,3 dihydro-2-oxo-3-benzo (b) thiophene-carboxamides
AU2160877A (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
GB1486546A (en) 4,4-diphenyl-cyclohexylpiperidine compounds and analogues thereof
JPS51101989A (en) 33n nnjimechirukarubamoirokishii11 mechiruu55 fueniruu77 kuroroo1 33 jihidoroo2hh1 44 benzojiazenn22onnoseizoho
AU491608B2 (en) 2, 2-difluoro prostaglandin analogues
AU495499B2 (en) 4, 5-didehydro prostaglandin analogues
IE45950L (en) 7ó-halosteroids.
IL52123A0 (en) 3,7-disubstituted cephalosporins and preparation thereof
AU496088B2 (en) Prostaglandin-type 1, 9-lactones
AU515311B2 (en) 3 (diphenylamino) phthalides

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee